Trust Investment Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$465K Sell
7,260
-1,704
-19% -$112K 0.22% 73
2026
Q1
$638K Sell
8,964
-412
-4% -$32.5K 0.37% 70
2025
Q4
$769K Buy
9,376
+730
+8% +$56.9K 0.41% 67
2025
Q3
$649K Buy
8,646
+197
+2% +$14.7K 0.37% 71
2025
Q2
$626K Sell
8,449
-120
-1% -$8.35K 0.38% 69
2025
Q1
$692K Buy
8,569
+219
+3% +$18.8K 0.45% 64
2024
Q4
$653K Buy
8,350
+2,979
+55% +$253K 0.42% 70
2024
Q3
$504K Buy
5,371
+135
+3% +$11.3K 0.32% 74
2024
Q2
$408K Buy
+5,236
New +$427K 0.26% 76

Other funds holding GEHC

Trust Investment Advisors's GEHC Position: Q2 2026 in Review

Trust Investment Advisors reduced its GE HealthCare (GEHC) stake by 19% in Q2 2026, selling an estimated $112K and leaving 7,260 shares worth $465K. The position accounts for 0.22% of the portfolio, ranked #73.

Trust Investment Advisors first reported a position in GEHC in Q2 2024 and has held it in 9 quarters since. The position peaked at $769K in Q4 2025. 333 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Trust Investment Advisors held 7,260 shares of GE HealthCare worth $465K as of Q2 2026.
  • Trust Investment Advisors sold 1,704 GE HealthCare shares in Q2 2026, an estimated $112K.
  • GE HealthCare made up 0.22% of Trust Investment Advisors's portfolio in Q2 2026, its #73 holding.
  • Trust Investment Advisors first reported a position in GE HealthCare in Q2 2024 and has held it in 9 quarters since.
  • Trust Investment Advisors's GE HealthCare position peaked at $769K in Q4 2025.
  • 333 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Trust Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.